BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21122538)

  • 1. Factors that modify therapy adherence in patients with inflammatory bowel disease.
    Bermejo F; López-San Román A; Algaba A; Guerra I; Valer P; García-Garzón S; Piqueras B; Villa C; Bermejo A; Rodríguez-Agulló JL
    J Crohns Colitis; 2010 Oct; 4(4):422-6. PubMed ID: 21122538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.
    Nahon S; Lahmek P; Saas C; Durance C; Olympie A; Lesgourgues B; Gendre JP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1270-6. PubMed ID: 21560190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
    Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ
    Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.
    Hawthorne AB; Rubin G; Ghosh S
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1157-66. PubMed ID: 18384664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?
    Horváth G; Farkas K; Hollósi R; Nagy F; Szepes Z; Papp M; Palatka K; Miheller P; Lakatos L; Szamosi T; Nyári T; Wittmann T; Molnár T
    Scand J Gastroenterol; 2012 Nov; 47(11):1298-303. PubMed ID: 22935014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!
    Banerjee R; Pal P; Adigopula B; Reddy DN
    J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):e92-e99. PubMed ID: 33405436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying predictors of low adherence in patients with inflammatory bowel disease.
    Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
    de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
    Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study.
    Baars JE; Zelinkova Z; Mensink PB; Markus T; Looman CW; Kuipers EJ; Van Der Woude CJ
    Aliment Pharmacol Ther; 2009 Oct; 30(8):864-72. PubMed ID: 19706149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.
    Tae CH; Jung SA; Moon HS; Seo JA; Song HK; Moon CM; Kim SE; Shim KN; Jung HK
    J Clin Gastroenterol; 2016 Feb; 50(2):157-62. PubMed ID: 26501880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beliefs About Medicines and Adherence to Treatment in Turkish Patients with Inflammatory Bowel Disease.
    Can G; Yozgat A; Tezel A; Ünsal G; Soylu AR
    Turk J Gastroenterol; 2022 Sep; 33(9):743-750. PubMed ID: 35946875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.
    Horne R; Parham R; Driscoll R; Robinson A
    Inflamm Bowel Dis; 2009 Jun; 15(6):837-44. PubMed ID: 19107771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets.
    Ribaldone DG; Vernero M; Saracco GM; Pellicano R; Finocchiaro F; Caviglia GP; Astegiano M
    Scand J Gastroenterol; 2018 Feb; 53(2):141-146. PubMed ID: 29228844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to treatment in inflammatory bowel disease.
    López San Román A; Bermejo F; Carrera E; Pérez-Abad M; Boixeda D
    Rev Esp Enferm Dig; 2005 Apr; 97(4):249-57. PubMed ID: 15982180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.